Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer

Fig. 1

Landscape of the somatic and copy number variation (CNV) mutations of m6A regulators in bladder cancer (BCa). A The mutation profile of 24 m6A regulators in patients with BCa. The upper barplot indicates the tumor mutational burden (TMB) of individual patients, and the number on the right shows the mutation frequency in each regulator. B The m6A somatic mutation co-occurrence and mutually exclusion analyses of 24 m6A regulators. Co-occurrence to mutual exclusion from green to brown. C The CNV variation frequency of m6A regulators in BCa. The blue column represents the deletion frequency, and the red column represents the amplification frequency. D The location of CNV alteration of m6A regulators on different chromosomes. ·P < 0.05; *P < 0.001

Back to article page